Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection-Reference-Cited by-同舟云学术

Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection

Published:2011-08 Issue:2 Volume:140 Page:130-141
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Schneiders Famke L.,Scheper Rik J.,von Blomberg B. Mary E.,Woltman Andrea M.,Janssen Harry L.A.,van den Eertwegh Alfons J.M.,Verheul Henk M.W.,de Gruijl Tanja D.,van der Vliet Hans J.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference55 articles.

1. A novel population of T-cell receptor alpha beta-bearing thymocytes which predominantly expresses a single V beta gene family;Fowlkes;Nature,1987

2. Requirements for CD1d recognition by human invariant Valpha24+ CD4−CD8− T cells;Exley;J. Exp. Med.,1997

3. Dominant expression of a distinctive V14+ T-cell antigen receptor alpha chain in mice;Koseki;Proc. Natl. Acad. Sci. U. S. A.,1991

4. An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4–8− T cells;Dellabona;J. Exp. Med.,1994

5. KRN7000, a novel immunomodulator, and its antitumor activities;Kobayashi;Oncol. Res.,1995

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. invariant Natural Killer T cell therapy as a novel therapeutic approach in hematological malignancies;Frontiers in Transplantation;2024-05-06

2. Preclinical evaluation of therapeutic vaccines for chronic hepatitis B that stimulate antiviral activities of T cells and NKT cells;JHEP Reports;2024-05

3. A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome;Nature Communications;2024-02-06

4. Novel lipid antigens for NKT cells in cancer;Frontiers in Immunology;2023-10-16

5. Oncoviruses: How do they hijack their host and current treatment regimes;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-09